PD‐1 inhibitors for non‐small cell lung cancer patients with special issues: Real‐world evidence

PD‐1 inhibitors for non‐small cell lung cancer patients with special issues: Real‐world evidence

Abstract Background Immune checkpoint inhibitors (ICIs) have provided new therapeutic options for non‐small cell lung cancer(NSCLC) patients. However, due to concerning increases in immune‐related adverse events, clinical trials usually exclude patients with special issues such as viral hepatitis, t...

Full description

Bibliographic Details
Main Authors:	Seonggyu Byeon, Jang Ho Cho, Hyun Ae Jung, Jong‐Mu Sun, Se‐Hoon Lee, Jin Seok Ahn, Keunchil Park, Myung‐Ju Ahn
Format:	Article
Language:	English
Published:	Wiley 2020-04-01
Series:	Cancer Medicine
Subjects:	autoimmune disease hepatitis B virus immune checkpoint inhibitors interstitial lung disease non‐small cell lung cancer tuberculosis
Online Access:	https://doi.org/10.1002/cam4.2868

Similar Items

Efficacy and Safety of Rituximab in Autoimmune Disease—Associated Interstitial Lung Disease: A Prospective Cohort Study
by: Natalia Mena-Vázquez, et al.
Published: (2022-02-01)

Characteristics and risk factors of mortality in patients with systemic sclerosis-associated interstitial lung disease
by: Hye Jin Jang, et al.
Published: (2023-12-01)

Interstitial Lung Disease with Autoimmune Features Successfully Treated with Mycophenolate Mofetil: Case Report
by: Sabrina Khuder, et al.
Published: (2023-12-01)

Recent advances in the diagnosis and management of interstitial pneumonia with autoimmune features: the perspective of rheumatologists
by: Hong Ki Min, et al.
Published: (2021-05-01)

Acetylated Diacylglycerol 1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol in Autoimmune Arthritis and Interstitial Lung Disease in SKG Mice
by: Doo-Ho Lim, et al.
Published: (2021-08-01)

The Role of Nintedanib in the Treatment of Progressive Pulmonary Fibrosis of Autoimmune-Related Interstitial Lung Disease
by: Aulia Rahman Ardan, et al.
Published: (2023-11-01)

Rituximab in the Treatment of Interstitial Lung Disease Associated with Autoimmune Diseases: Experience from a Single Referral Center and Literature Review
by: Belén Atienza-Mateo, et al.
Published: (2020-09-01)

The Spectrum of Interstitial Lung Disease Associated with Autoimmune Diseases: Data of a 3.6-Year Prospective Study from a Referral Center of Interstitial Lung Disease and Lung Transplantation <sup>†</sup>
by: Belén Atienza-Mateo, et al.
Published: (2020-05-01)

Descriptive study of the role of ultrasound in the evaluation of patients with interstitial lung disease associated with autoimmune connective tissue disorders
by: Varghese Koshy, et al.
Published: (2023-01-01)

Australasian interstitial lung disease registry (AILDR): objectives, design and rationale of a bi-national prospective database
by: Irene Moore, et al.
Published: (2020-10-01)

Interstitial pneumonia with autoimmune features: monocentric prospective study
by: Larisa A. Akulkina, et al.
Published: (2023-04-01)

Interstitial pneumonia with autoimmune features: A case series and overview
by: Ana Luísa Fernandes, et al.
Published: (2021-01-01)

Clinical outcomes of interstitial lung abnormalities: a systematic review and meta-analysis
by: Jinwoo Seok, et al.
Published: (2024-03-01)

Interstitial Pneumonia with Autoimmune Features: Why Rheumatologist-Pulmonologist Collaboration Is Essential
by: Marco Sebastiani, et al.
Published: (2020-12-01)

Serological and morphological prognostic factors in patients with interstitial pneumonia with autoimmune features
by: Yuhei Ito, et al.
Published: (2017-08-01)

Endothelin-1 as a Biomarker of Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Associated with Autoimmune Diseases
by: Verónica Pulito-Cueto, et al.
Published: (2023-01-01)

The Role of Small Airway Disease in Pulmonary Fibrotic Diseases
by: Georgios I. Barkas, et al.
Published: (2023-11-01)

Clinical characteristics associated with occurrence and poor prognosis of interstitial lung disease in rheumatoid arthritis
by: Ji Ae Yang, et al.
Published: (2019-03-01)

Autoantibodies as biomarkers for interstitial lung disease in idiopathic inflammatory myositis and systemic sclerosis: The case of anti-eIF2B antibodies
by: Angela Ceribelli, et al.
Published: (2020-01-01)

Variety of lung involvement in autoimmune liver diseases
by: L A Akulkina, et al.
Published: (2018-08-01)

Animal models of rheumatoid arthritis‐associated interstitial lung disease
by: Li Xiong, et al.
Published: (2021-03-01)

Mycophenolate therapy in interstitial pneumonia with autoimmune features: a cohort study
by: McCoy SS, et al.
Published: (2018-11-01)

Pulmonary alveolar proteinosis with an unusual bronchoscopic complication
by: Duncan J. Sweeney, et al.
Published: (2021-11-01)

Surfactant protein-D predicts prognosis of interstitial lung disease induced by anticancer agents in advanced lung cancer: a case control study
by: Kota Nakamura, et al.
Published: (2017-05-01)

Risk factors for acute exacerbation in lung cancer complicated by interstitial lung disease with slight reticular shadows
by: Yutaka Takahara, et al.
Published: (2021-10-01)

Pre‐existing interstitial lung disease does not affect prognosis in non‐small cell lung cancer patients with PD‐L1 expression ≥50% on first‐line pembrolizumab
by: Ou Yamaguchi, et al.
Published: (2021-02-01)

Pembrolizumab‐induced interstitial lung disease following thoracic surgery in a patient with non‐small cell lung cancer
by: Tetsuo Fujita, et al.
Published: (2019-11-01)

Dilemma of diagnosing thoracic sarcoidosis in tuberculosis endemic regions: An imaging-based approach. Part 1
by: Ashu S Bhalla, et al.
Published: (2017-10-01)

Pulmonary IgG4‐related disease with favourable response to rituximab: A case report
by: Romain Muller, et al.
Published: (2022-12-01)

Potential Role of JAK Inhibitors in the Treatment of Systemic Sclerosis-Associated Interstitial Lung Disease: A Narrative Review from Pathogenesis to Real-Life Data
by: Elisa Fiorentini, et al.
Published: (2022-12-01)

Characteristics and Predictors of Progression Interstitial Lung Disease in Rheumatoid Arthritis Compared with Other Autoimmune Disease: A Retrospective Cohort Study
by: Natalia Mena-Vázquez, et al.
Published: (2021-09-01)

One‐year clinical experience on the use of Nintedanib in systemic sclerosis
by: Luca Magnani, et al.
Published: (2023-06-01)

Multi-disciplinary team approach in the management of connective tissue disease-interstitial lung disease: The way forward
by: Ben Rowlands, et al.
Published: (2021-01-01)

Anti-synthetase syndrome: a rare and challenging diagnosis for bilateral ground-glass opacities—a case report with literature review
by: Nasam Alfraji, et al.
Published: (2021-01-01)

Connective tissue disease-related interstitial lung disease (CTD-ILD) and interstitial lung abnormality (ILA): Evolving concept of CT findings, pathology and management
by: Hongseok Yoo, et al.
Published: (2022-01-01)

Respiratory diseases and obesity: special phenotype or independent events: Review
by: Evgeniy I. Shchepikhin, et al.
Published: (2022-03-01)

High mortality and poor treatment efficacy of immune checkpoint inhibitors in patients with severe grade checkpoint inhibitor pneumonitis in non‐small cell lung cancer
by: Mari Tone, et al.
Published: (2019-10-01)

Linking Adiposity to Interstitial Lung Disease: The Role of the Dysfunctional Adipocyte and Inflammation
by: Michael Macklin, et al.
Published: (2023-09-01)

Pre-Existing Interstitial Lung Abnormalities Are Independent Risk Factors for Interstitial Lung Disease during Durvalumab Treatment after Chemoradiotherapy in Patients with Locally Advanced Non-Small-Cell Lung Cancer
by: Wakako Daido, et al.
Published: (2022-12-01)

Towards the Essence of Progressiveness: Bringing Progressive Fibrosing Interstitial Lung Disease (PF-ILD) to the Next Stage
by: Laurens J. De Sadeleer, et al.
Published: (2020-06-01)